Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange ProgramM. John Gill, Marie‐Josée Brouillette, Francisco Bernal-Cano et al.|Clinical Infectious Diseases|2012Cited by 208
Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registryMaria Mazzitelli, Laura Comi, Domenico Pontillo et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 7
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO RegistryDaniele Armenia, Alessio Bellucci, Vincenzo Spagnuolo et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 6
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO RegistryDaniele Armenia, Silvia Magnani, Giovanni Marchegiani et al.|Journal of Antimicrobial Chemotherapy|2025Cited by 0